Publications by authors named "Xiangyun Mao"

Claim this Profile
T
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort study.
Xiangyun Mao, Haoyu Yin, Xiaoyin Bai, Aaron S Kesselheim, Guanqiao Li

Drug Discov Today· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough therapy designations in China and the United States.
Xiangyun Mao, Yi Li, Aaron S Kesselheim, Yi Ba, Guanqiao Li

Nat Rev Drug Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital health technology use in clinical trials of rare diseases: a systematic review.
Xiangyun Mao, Dian Zeng, Xiaocong Wang, David A Pearce, Gareth Baynam

Commun Med (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory flexibilities balancing unmet needs, benefits and risks in the approvals of imported cancer drugs in China: a cohort study from 2012 to 2021.
Xiangyun Mao, Jiachen Xu, Xiaozhen Liu, Shu Kong, Yi Li

Lancet Reg Health West Pac· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated approvals: Early-phase success or premature authorization?
Xiangyun Mao, G Caleb Alexander, Guanqiao Li

Cancer Cell· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis